Clinical features of cryptococcosis in patients with different immune statuses: a multicenter study in Jiangsu Province–China

Abstract

Background Current guidelines support different management of cryptococcosis between severely immunodeficient and immunocompetent populations. However, few studies have focused on cryptococcosis patients with mild-to-moderate immunodeficiency. We performed this study to determine the clinical features of pulmonary (PC) and extrapulmonary cryptococcosis (EPC) and compared them among populations with different immune statuses to support appropriate clinical management of this public health threat. Methods All cases were reported by 14 tertiary teaching hospitals in Jiangsu Province, China from January 2013 to December 2018. The trends in incidence, demographic data, medical history, clinical symptoms, laboratory test indicators, imaging characteristics and diagnostic method of these patients were then stratified by immune status, namely immunocompetent (IC, patients with no recognized underlying disease or those with an underlying disease that does not influence immunity, such as hypertension), mild-to-moderate immunodeficiency (MID, patients with diabetes mellitus, end-stage liver or kidney disease, autoimmune diseases treated with low-dose glucocorticoid therapy, and cancer treated with chemotherapy) and severe immunodeficiency (SID, patients with acquired immunodeficiency syndrome, haematologic malignancies, solid organ transplantation or haematologic stem cell transplantation, idiopathic CD4 lymphocytosis, agranulocytosis, aggressive glucocorticoid or immunosuppressive therapy and other conditions or treatments that result in severe immunosuppression). Results The clinical data of 255 cryptococcosis patients were collected. In total, 66.3% of patients (169) were IC, 16.9% (43) had MID, and 16.9% (43) had SID. 10.1% of the patients (17) with IC were EPC, 18.6% of the patients (8) with MID were EPC, and 74.4% of patients (32) were EPC (IC/MID vs. SID, p < 0.001). Fever was more common in the SID group than in the IC and MID groups (69.8% vs. 14.8% vs. 37.2%, p < 0.001). Of chest CT scan, most lesions were distributed under the pleura (72.7%), presenting as nodules/lumps (90.3%) or consolidations (10.7%). Pleural effusion was more common in SID group compared to IC group (33.3% vs. 2.4%, p < 0.001). Positivity rate on the serum capsular polysaccharide antigen detection (CrAg) test was higher in the SID group than in the other two groups [100.0% vs. 84.4% (MID) vs. 78.2% (IC), p = 0.013]. Positivity rate on the serum CrAg test was also higher in cryptococcal meningitis patients than in PC patients (100.0% vs. 79.5%, p = 0.015). Conclusions The clinical presentation of MID patients is intermediate between SID and IC patients and is similar to that of IC patients. The serum CrAg test is more sensitive for the identification of SID or EPC patients.

Clinical Diagnosis, Treatment, and Laboratory Detection of 50 Cases of Pulmonary Cryptococcosis

“…According to immune status, we divided patients into immunocompetent and immunocompromised groups [ 12 , 16 , 17 ]. In the immunocompetent group, no recognized underlying disease exists or the underlying disease does not affect immunity, such as hypertension.…”

“…According to a retrospective study in China, pulmonary cryptococcosis accounts for 60% of HIV-negative patients with normal immune function [ 9 ]. Patients with pulmonary cryptococcosis with different immune states have certain differences regarding clinical manifestations, laboratory test results, and imaging features [ 10 – 12 ]. Cryptococcus capsular antigen detection and pathological examination are the main methods for diagnosis, and surgical resection and antifungal medications are usually offered for treatment.…”

Opportunistic Infections in the Immunocompromised: Hiv Vs Non-HIV Patients - A Narrative Review

“…Calcineurin inhibitors appear to be associated with a decreased likelihood of central CNS involvement but are associated with an increased likelihood of skin, soft tissue and bone involvement 90 . Skin involvement is also common in SOT recipients (seen between 10-18% of patients 91,92 ). Cellulitis is an increased recognized presentation among these patients and may also be a manifestation of IRIS 93 .…”

Cryptococcosis: Identification of Risk Areas in the Brazilian Amazon

“…Until the 1960s, it was considered a rare disease with little clinical importance. In the 1980s, with the emergence of the human immunodeficiency virus (HIV), there was an increase in the number of infections caused by Cryptococcus, making it one of the most prevalent systemic infections worldwide [ 5 , 6 , 7 ].…”